Image 1SpecificationsOrganism/cell line/tissue*Persicaria minor* (leaf)SexNot applicableSequencer or array typeIllumina HiSeqTM 2500 in Rapid Run modeData formatFASTQExperimental factorsMJ and ABA treatmentsExperimental featuresControlled growth chamber set for 25 ± 2 °C with photoperiod of 16 h of light and 8 h of darknessConsentNot applicableSample source locationSelangor, Malaysia; GPS coordinates: (3° 16′14.63″ N, 101° 41′ 11.32″ E)

1. Direct link to deposited data {#s0005}
================================

<https://www.ncbi.nlm.nih.gov/sra/SRX2655642>; (MJ-treated).

<https://www.ncbi.nlm.nih.gov/sra/SRX2655643>; (MJ-treated).

<https://www.ncbi.nlm.nih.gov/sra/SRX2655644>; (ABA-treated).

<https://www.ncbi.nlm.nih.gov/sra/SRX2655645>; (ABA-treated).

<https://www.ncbi.nlm.nih.gov/sra/SRX2655646>; (Control).

<https://www.ncbi.nlm.nih.gov/sra/SRX2655647>; (Control).

2. Experimental design, materials and methods {#s0010}
=============================================

2.1. Plant materials {#s0015}
--------------------

*Persicaria minor* plants were grown on an MS solid medium in a growth chamber at 25 ± 2 °C with a photoperiod of 16 h of light and 8 h of darkness. Healthy, 45 day plants were selected for MJ and ABA elicitation, and leaves were sprayed with 100 μM of MJ and 100 μM of ABA, while the control plants were sprayed with distilled water. For MJ-treatment, leaves sample were harvested after 2 days (maximum gene expression was previosly reported after 2 days) [@bb0005], whereas; samples for ABA-treatment were harvested after 3 days. The harvested samples were blotted dry, frozen in liquid nitrogen and stored at − 80 °C for further total RNA extraction.

2.2. Total RNA extraction, quality control, library preparation and small RNA-seq {#s0020}
---------------------------------------------------------------------------------

Total RNA from leaf samples were extracted using Plant RNA purification reagent (Invitrogen, USA) based on manufacturer\'s protocol. Quantitation of extracted total RNA was carried out using Nanodrop 1000 (Thermo Fisher Scientific Inc., USA) whereas, the integrity of was determined by Agilent 2100 Bioanalyzer (Agilent Technology, USA), respectively. Total RNAs with a RIN value \> 7 were selected for library construction. NEBNext® Multiplex Small RNA Library Prep Set for Illumina® (Set 1) Kit was used for library construction using the manufacturer\'s protocol.

Two biological replicates were prepared for each treatment. The small-RNA samples were sequenced using the Illumina HiSeq 2500 platform. Reads with 50 bp (single-end read) were generated for individual samples.

2.3. Raw reads processing, annotation and classification {#s0025}
--------------------------------------------------------

CLC Genomic Workbench version 8 (<https://www.qiagenbioinformatics.com>/) was used to analyze the data. The analysis was carried out by removing adaptor and low quality sequences. The remaining sequences were filtered and the sequences between 18 bp to 30 bp were obtained ([Table 1](#t0005){ref-type="table"}). The filtered sequences were considered for annotation. Firstly, the sequences were mapped against 73 plant species data from miRBase version 21 [@bb0010]. The sequences with no hit in the miRBase were used for further annotation against Rfam database ([Table 2](#t0010){ref-type="table"}) for non-coding RNAs (tRNA, snoRNA, SnRNA, and rRNA) [@bb0015], [@bb0020]. The remaining sequences having no hit with the above databases were categorized as unannotated.Table 1Raw reads pre-analysis.Table 1SRA IDTotal number of readsNumber of reads after trimmingDiscarded readsSRX2655642 (MJ-treated)33,496,29219,094,70614,401,586SRX2655643 (MJ-treated)47,378,86023,823,12723,555,733SRX2655644 (ABA-treated)3,940,9412,459,7791,481,162SRX2655645 (ABA-treated)30,566,19120,683,7629,882,429SRX2655646 (Control)11,223,1896,609,3154,613,874SRX2655647 (Control)26,046,62015,337,04610,709,574Table 2Raw reads annotation analysis.Table 2SRA IDTotal number of sequence tagsAnnotation by miRBaseAnnotation by RfamUnannotatedSRX2655642 (MJ-treated)1,923,2352899110,8341,809,502SRX2655643 (MJ-treated)2,403,18826461268,6912,271,792SRX2655644 (ABA-treated)496,30623136,572459,503SRX2655645 (ABA-treated)2,665,163845101,1412,563,177SRX2655646 (Control)1,194,072154874,2741,118,250SRX2655647 (Control)2,511,22170093,9752,416,546

2.4. Differential miRNA expression analysis {#s0030}
-------------------------------------------

The expression of miRNAs in treated and control libraries was compared. To proceed with the differential expression analysis, the first step in the statistical analysis was the normalization of the data to transcripts per million (TPM) which was done using criterion: TPM = (actual miRNA count/total count of clean reads) ∗ 1,000,000. After the data normalization, the fold change (Fold change = log2 (miRNA TPM in the treatment library/miRNA TPM in the control library) and p-value was calculated using Baggerly\'s test [@bb0025]. Finally, differentially expressed miRNAs were filtered using False Discovery Rates (FDR) ≤ 0.05 and the absolute value log~2~ ratio ≥ 1. [Table 3](#t0015){ref-type="table"} showed the number of miRNAs that significantly affected by both treatment.Table 3Differential miRNAs expression analysis.Table 3.TreatmentsTotal miRNAs significantly affectedNumber of miRNAs upregulatedNumber of miRNAs downregulatedMJ treatment30127328ABA treatment33429
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